| Dr Louis A Nassef Jr, MD | |
|
100 N Academy Ave, Danville, PA 17822-9800 | |
| (570) 271-6144 | |
| (570) 271-6578 |
| Full Name | Dr Louis A Nassef Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 100 N Academy Ave, Danville, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659334548 | NPI | - | NPPES |
| 001012436 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD033196E (Pennsylvania) | Primary |
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
PENTAX Medical announces the addition of new dedicated electrosurgical and argon plasma coagulation platforms – the ENDO ARC and ENDO PLUS – to its therapeutic accessories range.
We celebrate our triumphs over adversity, but let's face it: We'd rather not experience difficulty at all. A new study ties that behavioral inclination to learning: When researchers added a bit of conflict to make a learning task more difficult, that additional conflict biased learning by reducing the influence of reward and increasing the influence of aversion to punishment.
The overall project will concentrate on three areas where Europe is in a relatively favourable position compared with the US - human tissue resources, ribonucleic acid (RNA) technology, and structural proteomics. However, the initial focus will be on the development of genomics targets in hepatocellular carcinoma (HCC) or liver cancer as it is one of the leading causes of cancer death worldwide and has a very poor prognosis.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
› Verified 9 days ago
| Entity Name | Geisinger-hm Joint Venture Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144876137 PECOS PAC ID: 1355676370 Enrollment ID: O20190826000803 |
News Archive
PENTAX Medical announces the addition of new dedicated electrosurgical and argon plasma coagulation platforms – the ENDO ARC and ENDO PLUS – to its therapeutic accessories range.
We celebrate our triumphs over adversity, but let's face it: We'd rather not experience difficulty at all. A new study ties that behavioral inclination to learning: When researchers added a bit of conflict to make a learning task more difficult, that additional conflict biased learning by reducing the influence of reward and increasing the influence of aversion to punishment.
The overall project will concentrate on three areas where Europe is in a relatively favourable position compared with the US - human tissue resources, ribonucleic acid (RNA) technology, and structural proteomics. However, the initial focus will be on the development of genomics targets in hepatocellular carcinoma (HCC) or liver cancer as it is one of the leading causes of cancer death worldwide and has a very poor prognosis.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Louis A Nassef Jr, MD 100 N Academy Ave, Danville, PA 17822-9800 Ph: (570) 271-6144 | Dr Louis A Nassef Jr, MD 100 N Academy Ave, Danville, PA 17822-9800 Ph: (570) 271-6144 |
News Archive
PENTAX Medical announces the addition of new dedicated electrosurgical and argon plasma coagulation platforms – the ENDO ARC and ENDO PLUS – to its therapeutic accessories range.
We celebrate our triumphs over adversity, but let's face it: We'd rather not experience difficulty at all. A new study ties that behavioral inclination to learning: When researchers added a bit of conflict to make a learning task more difficult, that additional conflict biased learning by reducing the influence of reward and increasing the influence of aversion to punishment.
The overall project will concentrate on three areas where Europe is in a relatively favourable position compared with the US - human tissue resources, ribonucleic acid (RNA) technology, and structural proteomics. However, the initial focus will be on the development of genomics targets in hepatocellular carcinoma (HCC) or liver cancer as it is one of the leading causes of cancer death worldwide and has a very poor prognosis.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
› Verified 9 days ago
Dr. Stanley Joseph Russin, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-214-9585 Fax: 570-214-9519 | |
Dr. Steven Bonebrake, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-5555 Fax: 570-271-5269 | |
Tatiana Parra, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6164 Fax: 570-271-6141 | |
Dr. Paul Flavian Simonelli, MD, PH.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Mc 01-11, Danville, PA 17822 Phone: 570-271-6655 Fax: 570-214-3967 | |
Dr. Taher M. Yahya, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6393 Fax: 570-271-5623 | |
Dr. Ion D. Bucaloiu, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6164 Fax: 570-271-6141 | |
Dr. Mark A Shelly, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6408 Fax: 570-271-5845 |